Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00752505 · ClinicalTrials.gov registry record · Phase 2

A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.

A Phase 2 study of Fibromyalgia, sponsored by Pfizer.

Completed
Registry status
Phase 2
Development phase
89
Enrollment target
7
Study locations

NCT00752505 is a Phase 2 study of Fibromyalgia that has completed, run by Pfizer. The registered enrollment target is 89 participants, below the 178-participant average among 76 other Fibromyalgia trials with a reported enrollment target (50% lower). The trial reports 7 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00752505, a Phase 2 study of Fibromyalgia, has completed, sponsored by Pfizer.

COMPLETED
Registry status
Phase 2
Development phase
89 participants
Enrollment target
7
Study locations

Study Summary

The study is designed to assess if esreboxetine can improve the cognitive function of patients with fibromyalgia. Cognitive function is defined as the ability to concentrate, remember things and make decisions or problem solve. The study is also designed to assess if there is a difference in cognitive function between fibromyalgia patients and matched control subjects.

Conditions Studied

Fibromyalgia

Interventions

  • DRUG Esreboxetine

Study Locations (7)

Florida

  • Pfizer Investigational Site - Destin
  • Pfizer Investigational Site - Fort Walton Beach

Michigan

  • Pfizer Investigational Site - Ann Arbor
  • Pfizer Investigational Site - Bingham Farms

Texas

  • Pfizer Investigational Site - Austin
  • Pfizer Investigational Site - Dallas

Oklahoma

  • Pfizer Investigational Site - Oklahoma City

Trial Details

FieldValue
Enrollment Target 89 participants
Start Date 2008-08
Est. Completion 2009-06
Phase Phase 2

Sponsor

Pfizer

1,845 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00752505

The ClinicalTrials.gov registry entry for NCT00752505 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 178-participant average among 76 other Fibromyalgia trials with a reported enrollment target (50% lower). The listed sponsor is Pfizer, which has 1,845 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 1 intervention - of which Esreboxetine is the first listed.

NCT00752505 reports 7 study locations spanning 4 distinct geographic areas - top geographies include Florida, Michigan, Texas.

Frequently Asked Questions

What is clinical trial NCT00752505 about?

NCT00752505 is a clinical study titled "A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.". The study is designed to assess if esreboxetine can improve the cognitive function of patients with fibromyalgia. Cognitive function is defined as the ability to concentrate, remember things and make decisions or problem solve. The study is also designed to assess if there is a difference in cogniti...

What is the current status of trial NCT00752505?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 89 participants. The study started on 2008-08. Estimated completion is 2009-06.

What conditions does trial NCT00752505 study?

This clinical trial studies the following conditions: Fibromyalgia.

What interventions are being tested in trial NCT00752505?

The interventions under investigation include: Esreboxetine (DRUG).

Who is sponsoring clinical trial NCT00752505?

This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00752505 being conducted?

This trial has 7 study locations across Florida, Michigan, Oklahoma, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Fibromyalgia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Fibromyalgia

All registered trials for this condition

Florida

All trials with a study site in Florida

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.